跳至主要内容
临床试验/NCT01002209
NCT01002209撤回2 期

Postoperative Hyperbaric Oxygen Treatments to Reduce Complications in Diabetic Patients Undergoing Vascular Surgery (HODiVA) - A Double Blind, Randomized Controlled Study

Karolinska Institutet2 个研究点 分布在 1 个国家开始时间: 2019年10月最近更新:
适应症

试验速览

阶段
2 期
状态
撤回
试验地点
2
主要终点
Time to complete healing of operative wounds

研究概览

简要总结

This trial aims to evaluate if hyperbaric oxygen treatment (HBO) given postoperatively is effective in reducing healing time and wound complications after lower extremity bypass surgery in patients with diabetes.

Hypothesis: Postoperative HBO treatment is effective in reducing complications in patients with diabetes undergoing peripheral vascular surgery

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients are eligible for inclusion if the following criteria are fulfilled
  • Informed consent obtained
  • Scheduled for lower extremity open vascular surgery
  • Diabetes treated with insulin or oral antidiabetic medicine
  • Age ≥ 18 years

排除标准

  • Contraindications to HBO therapy
  • Pregnancy (women of childbearing potential will undergo pregnancy test before inclusion)
  • Patients already in HBO treatment
  • Vascular reoperation
  • Creatinine > 250 mmol/L
  • NYHA class IV heart failure or severe cardiopulmonary disease with desaturation judged to be incompatible with safe HBO/ placebo therapy in a monoplace chamber
  • Clinically significant chronic obstructive pulmonary disease.
  • Acute sepsis.
  • Malignancy or other serious medical condition where it is likely that the patient will significantly deteriorate or not survive within the two years of follow up.
  • Simultaneous or previous (within 30 days prior to study entry participation in a clinical study using experimental drugs or devices.
  • Mental condition making the subject unable to understand the concepts and risk of the study

结局指标

主要结局

Time to complete healing of operative wounds

时间窗: 7-365 days

次要结局

  • Tissue perfusion and oxygenation on dorsum of foot on operated extremity as assessed by Transcutaneous oximetry during normobaric air breathing and after 6 min normobaric 100% oxygen challenge(day 3-5, 7 and 14, 28, 365 (plus minus 3 days))
  • The severity of wound infection defined as by ASEPSIS score: 0-10= satisfactory healing 11-20= disturbed healing 21-30= minor wound infection 31-40= moderate wound infection >40= severe wound infection.(highest score up to 30 days (plus minus 3 days))
  • SF-36 score(7, 14, 28, 365 days (plus minus 3 days))
  • Major amputation or death. This will be assessed as "amputation-free survival". A major amputation is defined as any ipsilateral amputation through or above the ankle.(0-365 days)
  • Number of wound infections at 7 days assessed by ASEPSIS score. A score over 20 will be considered as a wound infection.(7 days (plus minus 3 days))
  • Number of wound infections at 30 days assessed by ASEPSIS score. A score over 20 will be considered as a wound infection.(30 days (plus minus 3 days))
  • A combination of any wound infection and/or unhealed wounds at 30 days (combined endpoint).(30 days (plus minus 3 days))
  • HBO complications (confinement anxiety, barotrauma, oxygen convulsions)(During HBO treatment up to day 6)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验